Search Press releases Keywords From To 31 Jul 2015 UCB 2015 Half Year Report: Strong growth - at constant and actual exchange rates Read More 28 Jul 2015 UCB announces Phase 3 clinical trial program for epratuzumab in Systemic Lupus Erythematosus did not meet primary endpoint Read More 23 Jun 2015 Acquisition of own shares (June 23) Read More 22 Jun 2015 Impact of earlier use of NEUPRO® (rotigotine transdermal patch) in Parkinson’s disease patients discussed at first EAN congress Read More 15 Jun 2015 UCB announces first presentation of data from NEUPRO® (rotigotine transdermal patch) Phase 3 study in China at international congress Read More 15 Jun 2015 Positive results from Phase 3 study evaluating CIMZIA® (certolizumab pegol) in DMARD-naïve rheumatoid arthritis patients Read More Pagination First page Previous page Previous … Page 96 Page 97 Page 98 Page 99 Current page 100 Page 101 Page 102 Page 103 Page 104 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
